The expression of survivin mRNA in cancer cells after survivin siRNA transfection was lower than control siRNA treated cells, and treatment with TAT-IL-24-KDEL in survivin siRNA-transfected cells further downregulated the survivin mRNA expression level (Figure 5A). This evidence concerns the gene BIRC5 and cancer.